Dr. Jeffrey E. Rubnitz, MD
- Publications
- 266
- Clinical trials
- 12
- Industry payments
- $9,557
- Insurance carriers
- 4
- State licenses
- 2
- Practice address
- 262 Danny Thomas Pl, Memphis, TN 38105
- Practice phone
- Call (901) 595-3300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
St Jude Childrens Research Hospital
Memphis, Tennessee
Find Dr. Rubnitz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jeffrey E. Rubnitz is a pediatric hematology and oncology physician in Memphis, Tennessee
Dr. Rubnitz practices at St Jude Childrens Research Hospital in Memphis, Tennessee.
Dr. Rubnitz's NPI, 1174526750, was assigned on May 27, 2005. Dr. Rubnitz graduated from UC San Diego School of Medicine in 1988. Dr. Rubnitz holds Tennessee license 26350.
- NPI
- 1174526750NPI Registry (opens in a new tab)
- NPI enumeration date
- May 27, 2005
- NPI status
- Active
- Practice phone
- (901) 595-3300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1988
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Jeffrey E. Rubnitz practices at St Jude Childrens Research Hospital in Memphis, Tennessee
Dr. Rubnitz's primary practice is St Jude Childrens Research Hospital, at 262 Danny Thomas Pl, Memphis, TN 38105 in Shelby County. The practice phone is (901) 595-3300.
- St Jude Childrens Research Hospital262 Danny Thomas Pl, Memphis, TN 38105 · Shelby CountyPhone(901) 595-3300
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Jeffrey E. Rubnitz is affiliated with 1 site of care
Dr. Rubnitz's primary practice is St Jude Childrens Research Hospital in Memphis, Tennessee.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Jeffrey E. Rubnitz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubnitz practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| St Jude Childrens Research Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jeffrey E. Rubnitz is one of 141 pediatric hematologys and oncology physicians in Tennessee
Pediatric hematology-oncology is Dr. Rubnitz's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Rubnitz is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Rubnitz's licenses on file in 2 states: Tennessee and California.
Specialties and state licenses
- Pediatric hematology and oncology, TennesseePrimary
- California license
Pediatric hematologys and oncology physicians near Dr. Rubnitz
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jeffrey E. Rubnitz has 266 publications on record
Dmand AI links 266 papers to Dr. Rubnitz, published from 2002 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma and Antineoplastic Combined Chemotherapy Protocols. Dr. Rubnitz has published most often in Leukemia. Dr. Rubnitz's most frequent co-authors are Ching-Hon Pui, MD, Hiroto Inaba, MD and John T. Sandlund, MD.
Dr. Rubnitz's papers by year, 2016 to 2025
Topics Dr. Rubnitz writes about most
- Leukemia, Myeloid, Acute
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antineoplastic Combined Chemotherapy Protocols
- Cytarabine
- Remission Induction
- Neoplasm, Residual
- Antineoplastic Agents
- Oncogene Proteins, Fusion
Dr. Rubnitz's most frequent co-authors
- Ching-Hon Pui, MD102 shared papers
- Hiroto Inaba, MD63 shared papers
- John T. Sandlund, MD55 shared papers
Recent publications by Dr. Rubnitz
Pediatr Blood Cancer
Pediatr Blood Cancer
See who Dr. Rubnitz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rubnitz works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jeffrey E. Rubnitz has worked on 12 clinical trials
Dmand AI links Dr. Rubnitz to 12 clinical trials, 4 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Myelodysplastic Syndromes. St. Jude Children's Research Hospital sponsors the most, 8.
Clinical trials with Dr. Rubnitz by phase
- 4Phase 1: 4 trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Rubnitz's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
- Myelodysplastic Syndromes
- Hematologic Neoplasms
- Leukemia
Investigators on the most trials with Dr. Rubnitz
- Kenneth M. Heym, MD3 shared trials
- Norman James Lacayo, MD3 shared trials
- Barbara A. Degar, MD2 shared trials
Recent clinical trials with Dr. Rubnitz
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy (opens in a new tab)
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (opens in a new tab)
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia (opens in a new tab)
Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jeffrey E. Rubnitz received $9,557 in industry payments from 2017 to 2021
CMS Open Payments shows 16 general payments to Dr. Rubnitz from 4 drug and device companies from 2017 to 2021. Consulting fees make up the largest share, 99% of the total. Celgene Corporation paid the most, $3,750.
General payments to Dr. Rubnitz by program year, 2017 to 2021
General payments to Dr. Rubnitz by kind, 2017 to 2021
- Consulting fees$9,50199%
- Food and beverage$561%
Companies that paid Dr. Rubnitz the most, 2017 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jeffrey E. Rubnitz graduated from UC San Diego School of Medicine
Dr. Rubnitz graduated from UC San Diego School of Medicine in 1988.
- Medical school
- Board certified in pediatric hematology-oncology
Source: Dmand AI Professional Profile Data
Dr. Jeffrey E. Rubnitz accepts plans from 4 insurance carriers
Dr. Rubnitz is in network with 4 carriers, including United Healthcare, AR State Medicaid and GA State Medicaid. Medicaid plans come from the most carriers, 3. Check the plan with the practice before a visit.
- United Healthcare
- AR State Medicaid
- GA State Medicaid
- KY State Medicaid
Plan types Dr. Rubnitz accepts, by number of carriers
- Medicaid3
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Jeffrey E. Rubnitz's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jeffrey E. Rubnitz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jeffrey E. Rubnitz's NPI number?
Dr. Jeffrey E. Rubnitz's NPI number is 1174526750. It was assigned on May 27, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Jeffrey E. Rubnitz?
Dr. Jeffrey E. Rubnitz is a pediatric hematology and oncology physician in Memphis, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Jeffrey E. Rubnitz practice?
Dr. Rubnitz practices at 262 Danny Thomas Pl, Memphis, TN 38105. Dr. Rubnitz's primary practice is St Jude Childrens Research Hospital in Memphis, Tennessee.
What is Dr. Jeffrey E. Rubnitz's office phone number?
The practice phone on file for Dr. Rubnitz is (901) 595-3300.
What is Dr. Jeffrey E. Rubnitz's medical license number?
Dr. Rubnitz holds Tennessee license 26350, one of the licenses on file in 2 states.
Which states has Dr. Jeffrey E. Rubnitz been licensed in?
Dmand AI has state licenses on file for Dr. Rubnitz in Tennessee (1995 to 2026) and California (since 1989).
Is Dr. Jeffrey E. Rubnitz board certified?
Yes. Dr. Rubnitz is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Jeffrey E. Rubnitz go to medical school?
Dr. Rubnitz graduated from UC San Diego School of Medicine in 1988.
Has Dr. Jeffrey E. Rubnitz received payments from drug or device companies?
CMS Open Payments shows $9,557 in general payments to Dr. Rubnitz from 4 companies from 2017 to 2021. The largest total came from Celgene Corporation.
How long has Dr. Jeffrey E. Rubnitz been practicing?
Dr. Rubnitz graduated from medical school in 1988, 38 years ago.
Show 3 more questionsShow fewer questions
Does Dr. Jeffrey E. Rubnitz do research?
Dmand AI links 266 publications to Dr. Rubnitz, published from 2002 to 2025. Dr. Rubnitz has worked on 12 clinical trials.
Who does Dr. Jeffrey E. Rubnitz publish with?
Dr. Rubnitz's most frequent co-authors are Ching-Hon Pui, MD (102 shared papers), Hiroto Inaba, MD (63 shared papers) and John T. Sandlund, MD (55 shared papers).
What insurance does Dr. Jeffrey E. Rubnitz accept?
Dr. Rubnitz is in network with 4 carriers, including United Healthcare, AR State Medicaid and GA State Medicaid. Medicaid plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card